Return to homepagePandemic Pact

Neutralizing type I IFN autoantibodies as predictive biomarkers for severe COVID-19

Grant number: unknown

Grant search

Key facts

  • Disease

    COVID-19

  • Start & end year

    2021

  • Known Financial Commitments (USD)

    $0

  • Funder

    CAPNETZ

  • Principal Investigator

    Prof Dr rer nat Christine Goffinet

  • Research Location

    Germany

  • Lead Research Institution

    Charite - Universitaetsmedizin Berlin Institut für Virologie

  • Research Priority Alignment

    N/A

  • Research Category

    Clinical characterisation and management

  • Research Subcategory

    Disease pathogenesis

  • Special Interest Tags

    N/A

  • Study Type

    Unspecified

  • Clinical Trial Details

    N/A

  • Broad Policy Alignment

    Pending

  • Age Group

    Not Applicable

  • Vulnerable Population

    Not applicable

  • Occupations of Interest

    Not applicable

Abstract